{"slug":"classification","tag":"classification","variants":["classification"],"description":"No description yet","count":3,"kinds":{"person":3},"related":[{"slug":"breast","tag":"breast","shared":2},{"slug":"genomics","tag":"genomics","shared":2},{"slug":"aml","tag":"aml","shared":1},{"slug":"guidelines","tag":"guidelines","shared":1}],"records":[{"id":"charles-perou","kind":"person","name":"Charles M. Perou","route":"/people/charles-perou/","tldr":"Defined the molecular subtypes of breast cancer (luminal, HER2-enriched, basal-like) that clinicians now use every day."},{"id":"hartmut-dohner","kind":"person","name":"Hartmut Döhner","route":"/people/hartmut-dohner/","tldr":"Leads the European LeukemiaNet classification that defines how AML is diagnosed and risk-stratified worldwide."},{"id":"carlos-caldas","kind":"person","name":"Carlos Caldas","route":"/people/carlos-caldas/","tldr":"Led METABRIC, which used 2,000 tumours to define ten genomic subtypes of breast cancer and their long-term outcomes."}]}